FLUCONAZOLE IN SODIUM CHLORIDE 0.9% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluconazole In Sodium Chloride 0.9%, and what generic alternatives are available?
Fluconazole In Sodium Chloride 0.9% is a drug marketed by Baxter Hlthcare Corp, Dr Reddys, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Baxter Hlthcare, Hospira, Inforlife, Mylan Labs Ltd, West-ward Pharms Int, and Woodward. and is included in fourteen NDAs.
The generic ingredient in FLUCONAZOLE IN SODIUM CHLORIDE 0.9% is fluconazole. There are twenty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the fluconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluconazole In Sodium Chloride 0.9%
A generic version of FLUCONAZOLE IN SODIUM CHLORIDE 0.9% was approved as fluconazole by CHARTWELL on July 29th, 2004.
Summary for FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 14 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Clinical Trials: | 272 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLUCONAZOLE IN SODIUM CHLORIDE 0.9% at DailyMed |
Recent Clinical Trials for FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
FEMPHARMA Kft. | N/A |
PPD | Phase 1 |
Rehab Werida | N/A |
Pharmacology for FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
Drug Class | Azole Antifungal |
Mechanism of Action | Cytochrome P450 2C19 Inhibitors Cytochrome P450 2C9 Inhibitors Cytochrome P450 3A4 Inhibitors |